Norwest Venture Partners invests Rs 120 cr in Thyrocare

For Thyrocare, this is the second PE investment, after CX Partners had invested Rs 188 cr for a 30% stake in 2010

Limited, a Mumbai-based medical diagnostics services provider, has raised about Rs 120 crore from private equity firm- (NVP). Its is learnt that Thyrocare has diluted about 10% stake to NVP. As part of the agreement, Sohil Chand, Managing Director of NVP India, will join Thyrocare's board of directors.

The diagnostics market in India comes about Rs 10,000 crore. Thyrocare's network of 20,000 service centers which spans 1,000 cities across India covers more than 1 lakh doctors through 600 franchisees.

For Thyrocare, this is the second PE investment, after had invested Rs 188 crore for a 30% stake in 2010.

India's diagnostic sector has been in the radar of PE majors as the market is growing fast. Early this year, Singapore-based GIC invested $100 million in Vasan Healthcare, while Goldman Sachs invested about Rs 300 crore for 6% stake in Max India last year. In 2010, US-based TA Associates had invested $35 million in Dr Lal Pathlabs.

Private equity fund Avigo Capital Partners had picked up 9.27% stake for Rs 100 crore in a pre-Initial Public Offering (IPO) placement in (SRL) last year.

A Velumani, MD and CEO of Thyrocare Technologies Limited: "When CX Partners invested, we were motivated and ventured into Nueclear, (the in-vivo segment). Now with NVP investing, we will be exploring global markets."

Norwest Venture Partners manages over $3.7 billion in capital and has funded more than 500 companies.

image
Business Standard
177 22
Business Standard

Norwest Venture Partners invests Rs 120 cr in Thyrocare

For Thyrocare, this is the second PE investment, after CX Partners had invested Rs 188 cr for a 30% stake in 2010

Reghu Balakrishnan  |  Mumbai 



Limited, a Mumbai-based medical diagnostics services provider, has raised about Rs 120 crore from private equity firm- (NVP). Its is learnt that Thyrocare has diluted about 10% stake to NVP. As part of the agreement, Sohil Chand, Managing Director of NVP India, will join Thyrocare's board of directors.

The diagnostics market in India comes about Rs 10,000 crore. Thyrocare's network of 20,000 service centers which spans 1,000 cities across India covers more than 1 lakh doctors through 600 franchisees.

For Thyrocare, this is the second PE investment, after had invested Rs 188 crore for a 30% stake in 2010.

India's diagnostic sector has been in the radar of PE majors as the market is growing fast. Early this year, Singapore-based GIC invested $100 million in Vasan Healthcare, while Goldman Sachs invested about Rs 300 crore for 6% stake in Max India last year. In 2010, US-based TA Associates had invested $35 million in Dr Lal Pathlabs.



Private equity fund Avigo Capital Partners had picked up 9.27% stake for Rs 100 crore in a pre-Initial Public Offering (IPO) placement in (SRL) last year.

A Velumani, MD and CEO of Thyrocare Technologies Limited: "When CX Partners invested, we were motivated and ventured into Nueclear, (the in-vivo segment). Now with NVP investing, we will be exploring global markets."

Norwest Venture Partners manages over $3.7 billion in capital and has funded more than 500 companies.

RECOMMENDED FOR YOU

Norwest Venture Partners invests Rs 120 cr in Thyrocare

For Thyrocare, this is the second PE investment, after CX Partners had invested Rs 188 cr for a 30% stake in 2010

Thyrocare Technologies Limited, a Mumbai-based medical diagnostics services provider, has raised about Rs 120 crore from private equity firm- Norwest Venture Partners (NVP). Its is learnt that Thyrocare has diluted about 10% stake to NVP. As part of the agreement, Sohil Chand, Managing Director of NVP India, will join Thyrocare's board of directors.

Limited, a Mumbai-based medical diagnostics services provider, has raised about Rs 120 crore from private equity firm- (NVP). Its is learnt that Thyrocare has diluted about 10% stake to NVP. As part of the agreement, Sohil Chand, Managing Director of NVP India, will join Thyrocare's board of directors.

The diagnostics market in India comes about Rs 10,000 crore. Thyrocare's network of 20,000 service centers which spans 1,000 cities across India covers more than 1 lakh doctors through 600 franchisees.

For Thyrocare, this is the second PE investment, after had invested Rs 188 crore for a 30% stake in 2010.

India's diagnostic sector has been in the radar of PE majors as the market is growing fast. Early this year, Singapore-based GIC invested $100 million in Vasan Healthcare, while Goldman Sachs invested about Rs 300 crore for 6% stake in Max India last year. In 2010, US-based TA Associates had invested $35 million in Dr Lal Pathlabs.

Private equity fund Avigo Capital Partners had picked up 9.27% stake for Rs 100 crore in a pre-Initial Public Offering (IPO) placement in (SRL) last year.

A Velumani, MD and CEO of Thyrocare Technologies Limited: "When CX Partners invested, we were motivated and ventured into Nueclear, (the in-vivo segment). Now with NVP investing, we will be exploring global markets."

Norwest Venture Partners manages over $3.7 billion in capital and has funded more than 500 companies.

image
Business Standard
177 22
Widgets Magazine

More News

  • (From left to right) Dr Arvind Lal, CMD,  Dr Lal PathLabs Pvt Ltd and  Dr Om Manchanda, CEO, Lal PathLabs Pvt. Ltd at the announcement of Dr Lal PathLabs IPO in Mumbai (pic: Suryakant Niwate) Dr Lal PathLabs faces pricing pressure, margin erosion
  • AC sales to warm up as new norms kick in AC sales to warm up as new norms kick in
Widgets Magazine
Widgets Magazine

Upgrade To Premium Services

Welcome User

Business Standard is happy to inform you of the launch of "Business Standard Premium Services"

As a premium subscriber you get an across device unfettered access to a range of services which include:

  • Access Exclusive content - articles, features & opinion pieces
  • Weekly Industry/Genre specific newsletters - Choose multiple industries/genres
  • Access to 17 plus years of content archives
  • Set Stock price alerts for your portfolio and watch list and get them delivered to your e-mail box
  • End of day news alerts on 5 companies (via email)
  • NEW: Get seamless access to WSJ.com at a great price. No additional sign-up required.
 

Premium Services

In Partnership with

 

Dear Guest,

 

Welcome to the premium services of Business Standard brought to you courtesy FIS.
Kindly visit the Manage my subscription page to discover the benefits of this programme.

Enjoy Reading!
Team Business Standard